TORONTO--(BUSINESS WIRE)-- Biovail Corporation (NYSE, TSX: BVF) today announced that it will host a conference call and Webcast on Thursday, May 6, 2010, at 8:30 a.m. EDT, for Company executives to discuss first-quarter 2010 financial and operational results.
Following the discussion, Biovail executives will address inquiries from investment analysts.
A live Webcast of this call will be available through the Investor Relations section of Biovail’s Web site at www.biovail.com. To access the call live, please dial 416-695-6617 (Toronto and International callers) and 1-800-355-4959 (U.S. and Canada). Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays.
A replay of the conference call will be available until 7:00 p.m. EDT on Thursday, May 13, 2010, by dialing 416-695-5800 (Toronto and International callers) and 1-800-408-3053 (U.S. and Canada), using access code, 2058403#.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company’s Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [email protected].
Nelson F. Isabel, 905-286-3000
Vice-President, Investor Relations
& Corporate Communications
KEYWORDS: North America Canada
INDUSTRY KEYWORDS: Health Pharmaceutical Professional Services Finance